179 related articles for article (PubMed ID: 20054798)
1. [Antipsychotic agents and stimulants: a judicious combination?].
de Jong MH; Eussen ML; van Gool AR
Tijdschr Psychiatr; 2010; 52(1):57-61. PubMed ID: 20054798
[TBL] [Abstract][Full Text] [Related]
2. [ADD psychosis: treatment with antipsychotics and methylphenidate?].
Blom JD; Kooij JJ
Tijdschr Psychiatr; 2012; 54(1):89-93. PubMed ID: 22237615
[TBL] [Abstract][Full Text] [Related]
3. Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder.
Atmaca M; Ozler S; Topuz M; Goldstein S
J Atten Disord; 2009 Sep; 13(2):197-8. PubMed ID: 19380515
[TBL] [Abstract][Full Text] [Related]
4. Risperidone-to-methylphenidate switch reaction in children: three cases.
Sabuncuoglu O
J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate an effective treatment for ADHD?
McDougle CJ
J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
[No Abstract] [Full Text] [Related]
8. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
Kraemer M; Uekermann J; Wiltfang J; Kis B
Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
[TBL] [Abstract][Full Text] [Related]
9. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Rowles BM; Findling RL
Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
[TBL] [Abstract][Full Text] [Related]
10. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of adult ADHD with stimulants.
Spencer TJ
CNS Spectr; 2007 Apr; 12(4 Suppl 6):8-11. PubMed ID: 17715564
[No Abstract] [Full Text] [Related]
12. [Response to 'ADD psychosis: treatment with antipsychotics and methylphenidate?'].
Vergouwen T; Gorissen-Van Eenige M
Tijdschr Psychiatr; 2012; 54(3):308; author reply 309. PubMed ID: 22422425
[No Abstract] [Full Text] [Related]
13. Characteristics of patients with schizophrenia successive to childhood attention deficit hyperactivity disorder (ADHD).
Elman I; Sigler M; Kronenberg J; Lindenmayer JP; Doron A; Mendlovic S; Gaoni B
Isr J Psychiatry Relat Sci; 1998; 35(4):280-6. PubMed ID: 9988985
[TBL] [Abstract][Full Text] [Related]
14. Naturalistic long-term use of methylphenidate in bipolar disorder.
Lydon E; El-Mallakh RS
J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
16. Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.
Levy E; Traicu A; Iyer S; Malla A; Joober R
Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S48-52. PubMed ID: 25886680
[TBL] [Abstract][Full Text] [Related]
17. The association between medication for attention-deficit/hyperactivity disorder and cancer.
Steinhausen HC; Helenius D
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):208-13. PubMed ID: 23560601
[TBL] [Abstract][Full Text] [Related]
18. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
19. Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.
Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; van der Meer D; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):959-68. PubMed ID: 25395383
[TBL] [Abstract][Full Text] [Related]
20. Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting.
Corbeil O; Brodeur S; Courteau J; Béchard L; Huot-Lavoie M; Angelopoulos E; Di Stefano S; Marrone E; Vanasse A; Fleury MJ; Stip E; Lesage A; Joober R; Demers MF; Roy MA
Br J Psychiatry; 2024 Mar; 224(3):98-105. PubMed ID: 38044665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
